Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease.
about
Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directionsPreclinical Models for Investigation of Herbal Medicines in Liver Diseases: Update and PerspectiveLiver steatosis in hepatitis C patientsRole of mitochondria in nonalcoholic fatty liver diseaseOxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver diseaseA cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: Application to acetaminophenMitochondrial-nuclear genome interactions in non-alcoholic fatty liver disease in miceMechanisms of Liver Injury in Non-Alcoholic SteatohepatitisExposure to a northern contaminant mixture (NCM) alters hepatic energy and lipid metabolism exacerbating hepatic steatosis in obese JCR rats.Chronic enrichment of hepatic endoplasmic reticulum-mitochondria contact leads to mitochondrial dysfunction in obesity.Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategiesCerulenin blockade of fatty acid synthase reverses hepatic steatosis in ob/ob mice.High fat diet-induced modifications in membrane lipid and mitochondrial-membrane protein signatures precede the development of hepatic insulin resistance in miceMitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atherosclerosis and attenuates hepatic steatosis in apolipoprotein E-knockout mice.miR-181c regulates the mitochondrial genome, bioenergetics, and propensity for heart failure in vivo.Integrin α1-null mice exhibit improved fatty liver when fed a high fat diet despite severe hepatic insulin resistanceOxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease.Plasma and urine metabolic profiles are reflective of altered beta-oxidation in non-diabetic obese subjects and patients with type 2 diabetes mellitus.Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR ratsA Combination of Mitochondrial Oxidative Stress and Excess Fat/Calorie Intake Accelerates Steatohepatitis by Enhancing Hepatic CC Chemokine Production in Mice.Adipocytes as a Link Between Gut Microbiota-Derived Flagellin and Hepatocyte Fat Accumulation.A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model.Hyperinsulinemia shifted energy supply from glucose to ketone bodies in early nonalcoholic steatohepatitis from high-fat high-sucrose diet induced Bama minipigsReduced mitochondrial mass and function add to age-related susceptibility toward diet-induced fatty liver in C57BL/6J mice.Rifampicin-Induced Hepatic Lipid Accumulation: Association with Up-Regulation of Peroxisome Proliferator-Activated Receptor γ in Mouse LiverMitochondrial metabolism mediates oxidative stress and inflammation in fatty liver.In Situ Evaluation of Oxidative Stress in Rat Fatty Liver Induced by a Methionine- and Choline-Deficient DietEffects of high fat diets on rodent liver bioenergetics and oxidative imbalance.Role of CYP2E1 in mitochondrial dysfunction and hepatic tissue injury in alcoholic and non-alcoholic diseases.Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice.Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis.Head to Head Comparison of Short-Term Treatment with the NAD(+) Precursor Nicotinamide Mononucleotide (NMN) and 6 Weeks of Exercise in Obese Female Mice.Hepatic fatty acid trafficking: multiple forks in the roadPhenotypic comparison of common mouse strains developing high-fat diet-induced hepatosteatosis.Glutamate dehydrogenase activator BCH stimulating reductive amination prevents high fat/high fructose diet-induced steatohepatitis and hyperglycemia in C57BL/6J mice.PPARs and Mitochondrial Metabolism: From NAFLD to HCC.Mechanisms of Accelerated Liver Fibrosis Progression during HIV Infection.Liver Mitochondrial DNA Copy Number and Deletion Levels May Contribute to Nonalcoholic Fatty Liver Disease Susceptibility.Metabolomic analysis of the effects of chronic arsenic exposure in a mouse model of diet-induced Fatty liver disease.A lipid-rich gestational diet predisposes offspring to nonalcoholic fatty liver disease: a potential sequence of events.
P2860
Q26751258-49FC7332-7B43-46D1-983E-6E07841DDA94Q26768482-B9B3AB73-2364-40CB-A696-A0EE4384E5C2Q27010631-1D9097A0-08E8-4D54-927A-0FD7E235E52BQ27028142-D6CF2509-7BC5-43A5-9B1F-411C09528073Q28396128-7D69E2D1-F68C-4B78-9148-D15D915304C9Q28396747-324C8E66-9A69-4FC6-9225-0A3D07F7E456Q33861769-14FEAF54-78C1-430B-9278-FCABD275BBBFQ33898945-5D9793DA-CCE8-408E-BDEA-79B0BA15D31BQ34182714-CF93837D-D0C8-42C3-B67B-F1700F0C9A11Q34449244-CB4EFCCA-1B0E-4BED-99CF-FD7D970511ECQ34657286-548378CF-685B-4119-86EA-196294F97AF3Q35006116-1FCACDED-B4CD-4086-B1FD-BA6AAF106AA4Q35040495-8436C4FD-CEC6-451F-BDEE-93727FB6E00BQ35115065-C3D6BCB2-700D-4823-82D7-B2C915747371Q35165504-4BF54F06-497A-448D-9A27-3A7A06CA8924Q35173020-A02FE8D8-CF44-48BE-A2ED-4F40CFBF3487Q35183888-FD3D49B0-2FF4-4BDB-9C99-0B9BA1EF5043Q35559687-1EDC8A52-80C0-4573-AED8-82F6654B3FC5Q35559692-24399D55-6EC0-4EEA-9135-C9D5908FC494Q35888631-CC964399-266D-443B-B20D-50D7D50C3004Q35976370-1EB33B3E-326A-47B2-BFEE-237A0CCF5BC3Q36005098-F5F5F19E-28CE-4722-A70A-AF185A069097Q36049336-819F6836-3C09-4E67-9377-0BA6C0D21C12Q36150744-637BC3B4-49FB-42E6-8536-05825E95F709Q36180478-52B2E48D-F56D-4415-809A-AFFA555DBEF5Q36335957-DB885D10-430D-489A-A07A-FC699CF8FE4AQ36531596-EA369123-66DB-4A73-A40C-9FA81C46464DQ36579352-5AE9BAF2-52DA-4AF0-A156-465F335C1518Q36590615-57401F67-0FD6-4392-BBDB-1742532ADE21Q36723099-9C1C0488-EE00-4F24-93DF-06921782C5B4Q36740555-95C68B2A-E80A-4124-8D52-BF4055F15D6AQ37188040-7A2BE9F5-BD57-43F3-BF4A-CE71616DA391Q37296476-4CA70F91-51A5-4B91-A76C-1DC927CAA42CQ37373139-BDC37C8D-76F2-4CB2-809A-E237435DFD0AQ37428035-BAD954DE-72F8-48E2-9055-8CE4830BB21CQ37575571-50848C80-D444-4BB9-A8EA-936DC29A3A1CQ37578291-41C8EF0F-4ED1-46EA-AED6-9C6DD9371E0EQ37587055-001F93AD-ED3F-447F-8A84-ECB340BBD877Q37624181-A297EF29-B57A-4DAE-BA10-CDC36AEA2703Q37636507-F1FF125C-0E49-4083-BB1F-6BC6789A5768
P2860
Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease.
@en
type
label
Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease.
@en
prefLabel
Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease.
@en
P2093
P356
P1433
P1476
Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease.
@en
P2093
Bernard Fromenty
Karima Begriche
Marie-Anne Robin
P304
P356
10.1002/HEP.26226
P407
P577
2013-08-07T00:00:00Z